National Health Investors (NYSE:NHI) issued an update on its FY20 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $5.67-$5.71 for the period, compared to the Thomson Reuters consensus estimate of $5.66. National Health Investors also updated its FY 2020
Pre-Market guidance to 5.31-5.35 EPS.
NYSE:NHI opened at $90.79 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 16.40 and a quick ratio of 14.11. The business has a fifty day simple moving average of $85.11 and a two-hundred day simple moving average of $82.83. National Health Investors has a 1 year low of $73.62 and a 1 year high of $91.00. The company has a market capitalization of $4.02 billion, a P/E ratio of 16.39 and a beta of 0.29.
National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.95 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.41 by ($0.46). National Health Investors had a return on equity of 11.07% and a net margin of 50.44%. The firm had revenue of $82.20 million during the quarter, compared to analysts’ expectations of $79.92 million. During the same period in the prior year, the business earned $1.35 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, analysts anticipate that National Health Investors will post 5.69 earnings per share for the current year.
Several equities analysts have recently weighed in on NHI shares. BMO Capital Markets upgraded National Health Investors from an underperform rating to a market perform rating and lifted their price target for the company from $74.00 to $82.00 in a research report on Tuesday, January 7th. Mizuho reiterated a buy rating and issued a $95.00 price target on shares of National Health Investors in a research report on Friday, December 20th. Berenberg Bank started coverage on National Health Investors in a research report on Wednesday, February 5th. They issued a buy rating and a $94.00 price target for the company. ValuEngine upgraded National Health Investors from a sell rating to a hold rating in a research report on Friday, October 25th. Finally, Zacks Investment Research cut National Health Investors from a hold rating to a sell rating in a research report on Saturday, November 9th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of $90.25.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: Cryptocurrencies
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.